The beleaguered company is already being sued by major partners like Walgreens over its faulty blood tests, and now hopes offering investors from Theranos’s latest funding round in 2015 double the shares will help stem more lawsuits, reports the Wall Street Journal. If the investors take the deal, they’ll get two shares for every share they purchased—but they have to promise not to sue the company. Some of their extra shares will reportedly come from founder Elizabeth Holmes’s own shares.MG
collectionsInnovation FestivalCurrent Issue
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system.
The major tech ecosystems that battle for our attention and dollars.
What’s next for hardware, software, and services.
The brave new world of automation, from AI to drones.
How our urban centers are building toward the future.
Most Creative People
See members of our Most Creative People in Business community: leaders who are shaping the future of business in creative ways.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company's distinctive lens.